Hosein Azimian
Overview
Explore the profile of Hosein Azimian including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
108
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mousavikia S, Matin M, Bahreyni Tossi M, Azimian H
Biochim Biophys Acta Mol Cell Res
. 2025 Jan;
1872(3):119910.
PMID: 39889832
The P2X7 receptor, a key player in purinergic signaling, is a crucial factor in modulating the response of cancer cells to radiotherapy. The aim of this study was to elucidate...
2.
Dehghan N, Mousavikia S, Qasempour Y, Azimian H
Life Sci
. 2024 Nov;
359:123218.
PMID: 39510171
Radiotherapy as a treatment method for glioblastoma is limited due to the intrinsic apoptosis resistance mechanisms of the tumor. Administration of higher radiation doses contributes to toxicities in normal tissues...
3.
Darvish L, Bahreyni-Toossi M, Aghaee-Bakhtiari S, Akbari-Naserkiadeh A, Vaziri-Nezamdoust F, Azimian H
Gene
. 2024 Sep;
933:148951.
PMID: 39303820
Despite the success of radiotherapy for prostate cancer treatment, the recent discovery of radiation resistance prevents it from reaching its full potential. This study aims to use hsa-miR-7-5p for the...
4.
Shahram M, Azimian H, Abbasi B, Ganji Z, Khadem-Reza Z, Khakshour E, et al.
BMC Neurosci
. 2024 May;
25(1):26.
PMID: 38789970
Introduction: The challenge of treating Glioblastoma (GBM) tumors is due to various mechanisms that make the tumor resistant to radiation therapy. One of these mechanisms is hypoxia, and therefore, determining...
5.
Mollaee P, Azimian H, Ghadim N, Dolat E, Sheykhoo A, Bahreyni-Toossi M
J Cancer Res Ther
. 2024 Feb;
19(Suppl 2):S737-S742.
PMID: 38384048
No abstract available.
6.
Khakshour E, Bahreyni-Toossi M, Anvari K, Shahram M, Vaziri-Nezamdoust F, Azimian H
Mutat Res
. 2023 Dec;
828:111848.
PMID: 38154290
Purpose: Glioblastoma (GBM) is considered the most common and lethal type of brain tumor with a poor prognosis. GBM treatment has challenges due to its aggressive nature, which often causes...
7.
Sadeghi Moghadam M, Azimian H, Tavakol Afshari J, Toossi M, Farkhad N, Aghaee-Bakhtiari S
Stem Cells Int
. 2023 Sep;
2023:9991656.
PMID: 37674788
Background: Radiotherapy is a crucial treatment for most malignancies. However, it can cause several side effects, including the development of secondary malignancies due to radiation-induced genomic instability (RIGI). The aim...
8.
Kosarnia M, Bahreyni-Toossi M, Gholamhosseinian H, Dolat E, Fakour-Mollaee P, Azimian H
Radiat Prot Dosimetry
. 2023 Jul;
199(13):1410-1415.
PMID: 37448196
Radiation during radiotherapy and nuclear accidents is currently one of the biggest concerns for the international community. Biological dosimetry examines the amount of damage caused by radiation at the cellular...
9.
Darvish L, Bahreyni-Toossi M, Aghaee-Bakhtiari S, Firouzjaei A, Amraee A, Tarighatnia A, et al.
Mol Biol Rep
. 2023 Jun;
50(7):6063-6074.
PMID: 37294470
Background: One of the problems with radiation therapy (RT) is that prostate tumor cells are often radio-resistant, which results in treatment failure. This study aimed to determine the procedure involved...
10.
Darvish L, Toossi M, Azimian H, Shakeri M, Dolat E, Firouzjaei A, et al.
Cell Signal
. 2022 Dec;
104:110580.
PMID: 36581218
Resistance to cancer radiotherapy is one of the biggest concerns for success in treating and preventing recurrent disease. Malignant tumors may develop when they block genetic mutations associated with apoptosis...